One Biosciences: Valuation, Funding & Investors
One Biosciences is a biotechnology company specializing in AI-driven single cell transcriptomic profiling through its proprietary platform, OneMap™. The company focuses on enhancing oncology treatment decisions, patient selection, therapy development, and optimizing clinical trials, while also expanding strategic partnerships with pharmaceutical and biotechnology firms.
Leadership & Board
- Current Number of Employees
- 43
- Current LinkedIn Followers
- 8,348
Latest Estimated Valuation
- Total Amount Raised
- $32M
- Total Funding Rounds
- 2
- Latest Funding Amount
- $17M
- Latest Funding Round
- Series A
Employee Trend
One Biosciences had 43 employees as of November 9, 2026. The number of employees increased by 0 (0.00%) week-over-week.
43Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
One Biosciences had 8,348 followers as of November 9, 2026. The number of followers increased by 32 (0.38%) week-over-week.
8,348Latest Followers Count
32(0.38%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Aug 17, 2025 | Series A | $17.40M | ― |
| Jul 17, 2025 | Series A | $15.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| Redmile Group | Series A (2) |
| Blast. Club | Series A |
| Invus | Series A |
| Sofinnova Partners | Series A |
| Blast | Series A |
| Galion.exe | Series A |
| Adamed Technology | Series A |
| Polytechnique Ventures | Series A |
Similar Companies
A snapshot of private companies similar to One Biosciences, helping you discover and navigate related company profiles.
Related News and Analysis
